| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34694009_HAS_TOPIC_C0001792> <https://research.tib.eu/covid-19/entity/34694009_HAS_TOPIC_C0009324> <https://research.tib.eu/covid-19/entity/34694009_HAS_TOPIC_C0010346> <https://research.tib.eu/covid-19/entity/34694009_HAS_TOPIC_C0021390> <https://research.tib.eu/covid-19/entity/34694009_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34694009_HAS_TOPIC_C0156147> <https://research.tib.eu/covid-19/entity/34694009_HAS_TOPIC_C0678201> <https://research.tib.eu/covid-19/entity/34694009_HAS_TOPIC_C0678202> <https://research.tib.eu/covid-19/entity/34694009_HAS_TOPIC_C0949272> <https://research.tib.eu/covid-19/entity/34694009_HAS_TOPIC_C3537192> <https://research.tib.eu/covid-19/entity/34694009_HAS_TOPIC_C5200702> <https://research.tib.eu/covid-19/entity/34694009_HAS_TOPIC_C5200703> <https://research.tib.eu/covid-19/entity/34694009_HAS_TOPIC_C5200704> <https://research.tib.eu/covid-19/entity/34694009_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34694009_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/34694009_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Rho (Milan), Italy.\', \'Rome, Italy.\', \'Rozzano (Milan), Italy.\', \'Milan, Italy.\', \'Florence, Italy.\', \'San Giovanni Rotondo, Italy.\', \'Palermo, Italy.\', \'Naples, Italy.\', \'Monza, Italy.\', \'Turin, Italy.\', \'Padua, Italy.\', \'Vicenza, Italy.\', \'Brescia, Italy.\', \'Treviso, Italy.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Ardizzone_Sandro> <https://research.tib.eu/covid-19/entity/Armuzzi_Alessandro> <https://research.tib.eu/covid-19/entity/Balestrieri_Paola> <https://research.tib.eu/covid-19/entity/Bezzio_Cristina> <https://research.tib.eu/covid-19/entity/Cappello_Maria> <https://research.tib.eu/covid-19/entity/Caprioli_Flavio_Andrea> <https://research.tib.eu/covid-19/entity/Carparelli_Sonia> <https://research.tib.eu/covid-19/entity/Castiglione_Fabiana> <https://research.tib.eu/covid-19/entity/Daperno_Marco> <https://research.tib.eu/covid-19/entity/Felice_Carla> <https://research.tib.eu/covid-19/entity/Ferronato_Antonio> <https://research.tib.eu/covid-19/entity/Festa_Stefano> <https://research.tib.eu/covid-19/entity/Fiorino_Gionata> <https://research.tib.eu/covid-19/entity/Furfaro_Federica> <https://research.tib.eu/covid-19/entity/Imperatore_Nicola> <https://research.tib.eu/covid-19/entity/Milla_Monica> <https://research.tib.eu/covid-19/entity/Monterubbianesi_Rita> <https://research.tib.eu/covid-19/entity/Orlando_Ambrogio> <https://research.tib.eu/covid-19/entity/Pastorelli_Luca> <https://research.tib.eu/covid-19/entity/Ribaldone_Davide_Giuseppe> <https://research.tib.eu/covid-19/entity/Ricci_Chiara> <https://research.tib.eu/covid-19/entity/Saibeni_Simone> <https://research.tib.eu/covid-19/entity/Scucchi_Ludovica> <https://research.tib.eu/covid-19/entity/Vigan%C3%B2_Chiara> <https://research.tib.eu/covid-19/entity/Zingone_Fabiana>
?:doi	10.1111/apt.16663
?:doi	<https://research.tib.eu/covid-19/entity/10.1111/apt.16663>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Observational_Study>
?:journal	Alimentary pharmacology & therapeutics
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34694009>
?:pmid	<https://research.tib.eu/covid-19/entity/34694009>
?:pmid	34694009
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0009324_PROCESS_OF_C0030705> <https://research.tib.eu/covid-19/entity/C0030705_LOCATION_OF_C1825598> <https://research.tib.eu/covid-19/entity/C0032285_COEXISTS_WITH_C0009324> <https://research.tib.eu/covid-19/entity/C0231337_PROCESS_OF_C0030705> <https://research.tib.eu/covid-19/entity/C3272281_PROCESS_OF_C0030705> <https://research.tib.eu/covid-19/entity/C3806166_PROCESS_OF_C0683971>
?:title	Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/34694009>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/34694009>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all